FLT3 and acute myeloid leukemia: As information regarding the presence or absence of FLT3 mutations is required within days of diagnosis for the choice of proper treatment for AML, polymerase chain reaction (PCR) of bulk Deoxyribonucleic Acid (DNA) or Ribonucleic Acid (RNA) is employed in diagnostic laboratories [14].